NT69L blocks ethanol-induced increase of dopamine and glutamate levels in striatum of mouse

Neuroscience Letters

Volumn 487, Issue 3, 2011, Pages 322-324

  Li, Zhimin ^a   Boules, Mona ^a   Richelson, Elliott ^a  

^a MAYO CLINIC   (United States)

Author keywords

Dopamine; Ethanol; Glutamate; Neurotensin; NT69L; Striatum

Indexed keywords

ALCOHOL; DOPAMINE; GLUTAMIC ACID; NEUROTENSIN DERIVATIVE; NEUROTENSIN[8-13]; NT 69L; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CORPUS STRIATUM; DOPAMINE; ETHANOL; GLUTAMIC ACID; MALE; MICE; MICE, INBRED C57BL; MICRODIALYSIS; NEUROTENSIN; PEPTIDE FRAGMENTS;

EID: 78650523131     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.10.048     Document Type: Article

References (37)

1. Antonelli T., Fuxe K., Tomasini M.C., Mazzoni E., Agnati L.F., Tanganelli S., Ferraro L. Neurotensin receptor mechanisms and its modulation of glutamate transmission in the brain: relevance for neurodegenerative diseases and their treatment. Prog. Neurobiol. 2007, 83:92-109.
2. Binder E.B., Kinkead B., Owens M.J., Nemeroff C.B. Neurotensin and dopamine interactions. Pharmacol. Rev. 2001, 53:453-486.
3. Boules M., Fredrickson P., Richelson E. Neurotensin agonists as an alternative to antipsychotics. Expert Opin. Investig. Drugs 2005, 14:359-369.
4. Boules M., Warrington L., Fauq A., McCormick D., Richelson E. Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats. Eur. J. Pharmacol. 2001, 428:227-233.
5. Boules M., Warrington L., Fauq A., McCormick D., Richelson E. A novel neurotensin analog blocks cocaine- and d-amphetamine-induced hyperactivity. Eur. J. Pharmacol. 2001, 426:73-76.
6. Briody S., Boules M., Oliveros A., Fauq I., Richelson E. Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance. Behav. Brain Res. 2010, 207:118-124.
7. Burgevin M.C., Castel M.N., Quarteronet D., Chevet T., Laduron P.M. Neurotensin increases tyrosine hydroxylase messenger RNA-positive neurons in substantia nigra after retrograde axonal transport. Neuroscience 1992, 49:627-633.
8. Burgevin M.C., Laduron P.M., Quarteronnet D., Chevet T., Castel M.N. Striatal injection of neurotensin increases tyrosine hydroxylase mRNA in substantia nigra. Ann. N. Y. Acad. Sci. 1992, 668:311-313.
9. Campbell A.D., Erwin V.G. Chronic ethanol administration downregulates neurotensin receptors in long- and short-sleep mice. Pharmacol. Biochem. Behav. 1993, 45:95-106.
10. Ehlers C.L., Somes C., Li T.K., Lumeng L., Kinkead B., Owens M.J., Nemeroff C.B. Neurontensin studies in alcohol naive, preferring and non-preferring rats. Neuroscience 1999, 93:227-236.
11. Erwin V.G, Campbell A.D., Myers R., Womer D.E. Cross-tolerance between ethanol and neurotensin in mice selectively bred for ethanol sensitivity. Pharmacol. Biochem. Behav. 1995, 51:891-899.
12. Fredrickson P., Boules M., Yerbury S., Richelson E. Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats. Eur. J. Pharmacol. 2003, 458:111-118.
13. Fredrickson P., Boules M., Yerbury S., Richelson E. Novel neurotensin analog blocks the initiation and expression of nicotine-induced locomotor sensitization. Brain Res. 2003, 979:245-248.
14. Frye G.D., Luttinger D., Nemeroff C.B., Vogel R.A., Prange A.J., Breese G.R. Modification of the actions of ethanol by centrally active peptides. Peptides 1981, 2(Suppl 1):99-106.
15. Fuxe K., O'Connor W.T., Antonelli T., Osborne P.G., Tanganelli S., Agnati L.F., Ungerstedt U. Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:5591-5595.
16. Fuxe K., VonEuler G., Agnati L.F., Merlo Pich E., O'Connor W.T., Tanganelli S., Li X.M., Tinner B., Cintra A., Carani C., Benfenati F. Intramembrane interactions between neurotensin receptors and dopamine D2 receptors as a major mechanism for the neuroleptic-like action of neurotensin. Ann. N. Y. Acad. Sci. 1992, 668:186-204.
17. Gehle V.M., Erwin V.G. Common quantitative trait loci for alcohol-related behaviors and CNS neurotensin measures: voluntary ethanol consumption. Alcohol Clin. Exp. Res. 1998, 22:401-408.
18. Kinkead B., Nemeroff C.B. Neurotensin, schizophrenia, and antipsychotic drug action. Int. Rev. Neurobiol. 2004, 59:327-349.
19. Lee M.R, Hinton D.J., Song J.Y., Lee K.W., Choo C., Johng H., Unal S.S., Richelson E., Choi D.S. Neurotensin receptor type 1 regulates ethanol intoxication and consumption in mice. Pharmacol. Biochem. Behav. 2010, 95:235-241.
20. Leonetti M., Brun P., Clerget M., Steinberg R., Soubrie P., Renaud B., Suaud-Chagny M.F. Specific involvement of neurotensin type 1 receptor in the neurotensin-mediated in vivo dopamine efflux using knock-out mice. J. Neurochem. 2004, 89:1-6.
21. Li X.M., Ferraro L., Tanganelli S., O'Connor W.T., Hasselrot U., Ungerstedt U., Fuxe K. Neurotensin peptides antagonistically regulate postsynaptic dopamine D2 receptors in rat nucleus accumbens: a receptor binding and microdialysis study. J. Neural Transm. Gen. Sect. 1995, 102:125-137.
22. Li Z.M., Boules M., Williams K., Peris J., Richelson E. The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex. Brain Res. 2010, 1311:28-36.
23. Liang Y., Boules M., Shaw A.M., Williams K., Fredrickson P., Richelson E. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain. Brain Res. 2008, 1231:6-15.
24. Luttinger D, Nemeroff C.B., Mason G.A., Frye G.D., Breese G.R., Prange A.J. Enhancement of ethanol-induced sedation and hypothermia by centrally administered neurotensin, beta-endorphin and bombesin. Neuropharmacology 1981, 20:305-309.
25. Mazella J., Botto J.M., Guillemare E., Coppola T., Sarret P., Vincent J.P. Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain. J. Neurosci. 1996, 16:5613-5620.
26. Mazella J, Zsurger N., Navarro V., Chabry J., Kaghad M., Caput D., Ferrara P., Vita N., Gully D., Maffrand J.P., Vincent J.P. The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J. Biol. Chem. 1998, 273:26273-26276.
27. Moghaddam B., Bolinao M.L. Biphasic effect of ethanol on extracellular accumulation of glutamate in the hippocampus and the nucleus accumbens. Neurosci. Lett. 1994, 178:99-102.
28. Pettibone D.J., Hess J.F., Hey P.J., Jacobson M.A., Leviten M., Lis E.V., Mallorga P.J., Pascarella D.M., Snyder M.A., Williams J.B., Zeng Z. The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin. J. Pharmacol. Exp. Ther. 2002, 300:305-313.
29. Richelson E., Fredrickson P.A., Boules M.M. Neurotensin receptor agonists and antagonists for schizophrenia. Am. J. Psychiatr. 2005, 162:633-634. author reply 635.
30. Selim M., Bradberry C.W. Effect of ethanol on extracellular 5-HT and glutamate in the nucleus accumbens and prefrontal cortex: comparison between the Lewis and Fischer 344 rat strains. Brain Res. 1996, 716:157-164.
31. Shilling P.D., Melendez G., Priebe K., Richelson E., Feifel D. Neurotensin agonists block the prepulse inhibition deficits produced by a 5-HT2A and an alpha1 agonist. Psychopharmacology (Berlin) 2004, 175:353-359.
32. Smirnova T., Stinnakre J., Mallet J. Characterization of a presynaptic glutamate receptor. Science 1993, 262:430-433.
33. Szulc P., Zgliczynski W., Jeske W., Soszynski P., Roslonowska E., Nowakowski J., Zgliczynski S. The effect of oral ethanol ingestion on the diurnal neurotensin secretion in man. Endokrynol. Pol. 1992, 43:264-272.
34. Vita N., Laurent P., Lefort S., Chalon P., Dumont X., Kaghad M., Gully D., Le Fur G., Ferrara P., Caput D. Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. FEBS Lett. 1993, 317:139-142.
35. Yan Q.S., Reith M.E., Yan S.G., Jobe P.C. Effect of systemic ethanol on basal and stimulated glutamate releases in the nucleus accumbens of freely moving Sprague-Dawley rats: a microdialysis study. Neurosci. Lett. 1998, 258:29-32.
36. Yim H.J., Gonzales R.A. Ethanol-induced increases in dopamine extracellular concentration in rat nucleus accumbens are accounted for by increased release and not uptake inhibition. Alcohol 2000, 22:107-115.
37. Yim H.J., Robinson D.L., White M.L., Jaworski J.N., Randall P.K., Lancaster F.E., Gonzales R.A. Dissociation between the time course of ethanol and extracellular dopamine concentrations in the nucleus accumbens after a single intraperitoneal injection. Alcohol Clin. Exp. Res. 2000, 24:781-788.